News
Next week we're attending the 37th ACS National Medicinal Chemistry Symposium in New York. Meet the team at booth 15 to find out more about streamlining your small molecule discovery #chemistry. torx-software.com #medchem #smallmolecules #drugdiscovery #productivity pic.twitter.com/Lg9O4cGBiF
The analysis of new assay data is integral to making the right design decisions in the Design-Make-Test-Analyze (DMTA) cycle. Combining this ...
2021 has been a significant year in the life of Torx™ with the launch of the final two modules, Torx ...
In drug discovery, all newly synthesized small molecules must undergo first pass profiling through multiple assays to define SAR and ...
Cambridge, UK – 21 October 2021 – Torx Software Limited, provider of technology for managing small molecule discovery chemistry, announces ...
We are delighted to announce the release of the final modules of Torx™, your platform for small molecule discovery chemistry:
Discovery chemistry has progressed significantly in recent years. Researchers now have an abundance of information available to them, from computational ...
The ubiquitous Design-Make-Test-Analyze (DMTA) cycle provides a conerstone for drug discovery teams to consider and improve productivity. The challenge is ...
The delivery of synthesis targets within drug discovery often involves chemists from different organizations. Engaging contract research organization (CRO) partners ...
Chemistry teams working in small molecule discovery follow an iterative Design-Make-Test-Analyze (DMTA) cycle to design and optimize new therapeutics. Companies ...
Torx Design™ is a cloud-based platform that provides a central location to capture and share information about molecules, hypotheses and ...
Increased demands in pharmaceutical R&D have led to an increase in outsourcing The journey of a new drug from hypothesis ...
The importance of communication in drug discovery Every drug discovery program can be described using the iterative Design-Make-Test-Analyze (DMTA) workflow. ...
